March 13, 2015 — Infraredx announced it will premiere the Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter featuring Extended Bandwidth IVUS technology at the American College of Cardiology’s 2015 Annual Scientific Meeting in San Diego, March 14-16.
The Advanced TVC Imaging System is a U.S. Food and Drug Administration (FDA)-cleared technology capable of rapidly, specifically and reliably identifying lipid-core plaques (LCPs), which are known to complicate stenting procedures and suspected to cause most heart attacks.
By integrating near-infrared spectroscopy (NIRS) with intravascular ultrasound (IVUS), the Advanced TVC Imaging System enables quick, informed clinical decision-making and greater physician confidence in determining procedural and treatment strategies requiring information on vessel structure and plaque composition. This high-powered platform is designed to evolve with coronary care and incorporates advanced computing technology; high-definition monitors; an intuitive, user-friendly interface; and near-infrared laser optics for in vivo chemical analysis.
The system also includes Infraredx’s proprietary Extended Bandwidth IVUS technology, which harmonizes multiple signal frequencies to produce a sharp image of the complete vessel that allows for easy identification of the lumen, plaque and vessel structure.
In addition, a meeting of the Lipid-rich Plaque Study investigators will be held. This multicenter study is designed to test the hypothesis that true vessel characterization (TVC) imaging can identify the plaques likely to cause a heart attack. The study already has more 850 patients enrolled and is expected to yield a result in late 2015.
For more information: www.infraredx.com
November 07, 2024 
